
SearchTODAY Contentireland, a leading centre for egg donation?
Patients can now experience one-to-one treatment with consultants whom are leaders in the field of reproductive medicine in Dublin. Sims IVF has built a 7-year relationship with Intersono in the Ukraine, a leading IVF Clinic, chosen because in Western Europe, where the trend is to have children later in life, the number of recipients outstrips the number of available donors. READ MORE YESTERDAY contentWHAT IS ONCOFERTILITY?
Her research in reproductive endocrinology has increased awareness of fertility management and the role it plays in quality of life for the increasing number of women who are also young cancer survivors. In a wide ranging interview with Northwestern University’s Medill school Reports, in Chicago, Dr Woodruff says ''Oncofertility involves all the dimensions of a patient’s decision process and the provider’s information. It is the ethics, the law, the religious constraints..of fertility management' You can read the full interview here. ONE WEEK AGO contentDO YOU REALLY NEED FERTILITY TREATMENT?
Geoffrey Sher, co-founder and Executive Medical Director of the Sher Institutes for Reproductive Medicine (SIRM), has written a fascinating blog, about a study published online in the journal Fertility and Sterility which claims that about 44% of 7, 000 Australian women aged 28-36 years who said they had experienced difficulty conceiving for at least a year, subsequently achieved a pregnancy without having to undergo any type of fertility treatment. The authors concluded that almost half of “infertile” women in this age category probably don't need treatment. But, says Dr. Sher, it's not as simple or straightforward as that. QUICK TOUR |
HFEA HAS £3.4M TREASURE CHEST
publication date: Feb 16, 2012
The UK fertility watchdog, the HFEA (Human Fertility and Embryology Authority) has £3.4million of unspent funds, according to figures. Meanwhile thousands of woman are being refused free IVF treatment, due to budget cutbacks. The surplus cash could pay for approximately 850 cycles of treatment. A fee of £75is paid to the HFEA every time a woman has treatment. Last year a report by British MPs found three quarters of PCT's (primary care trusts) are denying women the three courses recommended by the health watchdog NICE. This includes five PCTs which refuse to pay for IVF altogether. Clare Lewis-Jones, from Infertility Network UK, and a member of the Multiply Magazine advisory panel' called for the surplus to be reinvested so other patients could benefit from the excess. ‘We believe the funds built up by the HFEA should be re-invested back into the area which they regulate and that infertility patients should in some way benefit from this excess.’ she said. Last year 45,000 women underwent IVF treatment in the UK, 60 per cent went privately. The HFEA has insisted that the money was accumulated through ‘prudent’ budgeting, and said it would be too ‘complex’ to try to give the money back to cash-strapped NHS trusts. The figures were obtained by the Health Service Journal. A poll in December revealed that a quarter of women having IVF said that they have to take out high-interest loans, reach their credit card limit and even re-mortgage their homes for a chance to realise their dream of motherhood. Dr Allan Pacey, of the British Fertility Society, said: ‘This comes at a time when NHS funding for infertility treatment such as IVF has been cut in many parts of the country as a cost cutting measure, and both hospital and household budgets are feeling the squeeze. The £3.4million is a significant sum of money and by a conservative estimate would fund over 850 cycles of IVF treatment. The BFS believes it is inappropriate for the regulator to amass such a sum, which by its own admission is “unusually large." We will be writing to the HFEA chief executive to ask for an explanation.’ A spokesman from the HFEA said: ‘Previously, we have agreed with the department not to pursue the possibility of returning the money to clinics due to the complex principles and practicalities that would entail. We developed proposals to enhance our capabilities in three ways, to spend the surplus money “wisely”, over three years. The Department of Health have told us that they cannot agree to this for the next financial year, and so we await the department’s alternative suggestions.’ |
|